Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Cooper

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|December 15, 1983
Protein A treatment of cancer: activation of a serum component with trans-species anti-B16 melanoma activityP D Cooper, G R Masinello
The Journal of General Virology|November 1, 1973
Temperature-sensitive poliovirus mutants defective in repression of host protein synthesis are also defective in structural proteinA Steiner-Pryor, P D Cooper
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1975
The genome of RNA tumor viruses: a functional requirement for a polyploid structure?P D Cooper, J A Wyke
Intervirology|January 1, 1974
Isolation of cold-sensitive mutants of poliovirusP J Wright, P D Cooper
Journal of Health Care Marketing|December 4, 1993
Consumer satisfaction and perceived quality of outpatient health servicesM Peyrot, P D Cooper, D Schnapf
Immunology Letters|February 1, 1991
Algammulin (gamma inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in miceP D Cooper, R Turner, J McGovern
Journal of Hospital Marketing|December 9, 1995
The status of marketing in the health care industry: perspectives of marketing practitionersF A Manu, P D Cooper, W Reinhart
Virology|March 1, 1970
Guanidine inhibition of poliovirus: a dependence of viral RNA synthesis on the configuration of structural proteinP D Cooper, B B Wentworth, D McCahon
Vaccine|June 1, 1991
The adjuvanticity of Algammulin, a new vaccine adjuvantP D Cooper, C McComb, E J Steele
Virology|April 1, 1970
Synthesis of double-stranded RNA by poliovirus temperature-sensitive mutantsP D Cooper, K Stancek, D F Summers
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|December 15, 1983
Protein A treatment of cancer: activation of a serum component with trans-species anti-B16 melanoma activityP D Cooper, G R Masinello
The Journal of General Virology|November 1, 1973
Temperature-sensitive poliovirus mutants defective in repression of host protein synthesis are also defective in structural proteinA Steiner-Pryor, P D Cooper
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1975
The genome of RNA tumor viruses: a functional requirement for a polyploid structure?P D Cooper, J A Wyke
Intervirology|January 1, 1974
Isolation of cold-sensitive mutants of poliovirusP J Wright, P D Cooper
Journal of Health Care Marketing|December 4, 1993
Consumer satisfaction and perceived quality of outpatient health servicesM Peyrot, P D Cooper, D Schnapf
Immunology Letters|February 1, 1991
Algammulin (gamma inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in miceP D Cooper, R Turner, J McGovern
Journal of Hospital Marketing|December 9, 1995
The status of marketing in the health care industry: perspectives of marketing practitionersF A Manu, P D Cooper, W Reinhart
Virology|March 1, 1970
Guanidine inhibition of poliovirus: a dependence of viral RNA synthesis on the configuration of structural proteinP D Cooper, B B Wentworth, D McCahon
Vaccine|June 1, 1991
The adjuvanticity of Algammulin, a new vaccine adjuvantP D Cooper, C McComb, E J Steele
Virology|April 1, 1970
Synthesis of double-stranded RNA by poliovirus temperature-sensitive mutantsP D Cooper, K Stancek, D F Summers
Pageof 8